Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 5 Hematologic toxicity associated with GFIP/BDC by type and grade

From: Use of a multi-drug regimen gemcitabine, 5-fluorouracil, irinotecan, cisplatin, bevacizumab, docetaxel, and cyclophosphamide (GFIP/BDC) for heavily pretreated relapsed epithelial ovarian, fallopian tube and primary peritoneal cancer

Toxicity None Grade 1 Grade 2 Grade 3 Grade 4
Anemia 0 1 1 1 0
Neutropenia 0 0 7 1 1
Thrombocytopenia 0 0 4 2 0